Evidence map›Paper›PMID 30818786›Full record

ReviewInternational journal of molecular sciences2019

A Review of Curcumin and Its Derivatives as Anticancer Agents.

Mhd Anas Tomeh, Roja Hadianamrei, Xiubo Zhao

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 370 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
370citing papers in PubMed, 1 pooled it
30.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

370 citing papers in PubMed, 1 synthesis or guideline pooled it, 909 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Experimental evaluation ofExperimental and therapeutic medicine · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Chemical constituents in the rhizome of Curcuma longa and the pharmacological importance of curcumin hybrids.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

310 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Mhd Anas TomehDepartment of Chemical and Biological Engineering, University of Sheffield, Sheffield S1 3JD, UK. matomeh1@sheffield.ac.uk.
Roja HadianamreiDepartment of Chemical and Biological Engineering, University of Sheffield, Sheffield S1 3JD, UK. rhadianamrei1@sheffield.ac.uk.
Xiubo ZhaoDepartment of Chemical and Biological Engineering, University of Sheffield, Sheffield S1 3JD, UK. xiubo.zhao@sheffield.ac.uk.ORCID 0000-0002-4620-2893
University of Sheffield · GBChangzhou University · CN

Funding

TRANSFORMATION OF B LYMPHOCYTES BY EPSTEIN-BARR VIRUSF32CA007174 · NCI · DANA-FARBER CANCER INSTITUTE · PI SPECK, SAMUEL H · 1985 to 1985
–
Engineering and Physical Sciences Research Council EP/N007174/1Engineering and Physical Sciences Research Council EP/N023579/1
6 · The paper itself

Abstract

Cancer is the second leading cause of death in the world and one of the major public health problems. Despite the great advances in cancer therapy, the incidence and mortality rates of cancer remain high. Therefore, the quest for more efficient and less toxic cancer treatment strategies is still at the forefront of current research. Curcumin, the active ingredient of the

Indexed as

AnimalsAntineoplastic AgentsCurcuminDrug Delivery SystemsHumansMolecular Targeted TherapyNeoplasmsStructure-Activity RelationshipAntineoplastic AgentsCurcuminanticancercellular pathwaycurcumindelivery systemmechanism of actionstructure activity relationship

Identifiers

PMID30818786
PMCPMC6429287
OpenAlexW2916045508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.